Bnp Paribas Asset Management Holding S.A. Abb Vie Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,064,433 shares of ABBV stock, worth $228 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
1,064,433
Previous 878,900
21.11%
Holding current value
$228 Million
Previous $174 Million
8.98%
% of portfolio
0.47%
Previous 0.43%
Shares
30 transactions
Others Institutions Holding ABBV
# of Institutions
4,107Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$37.1 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$29.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$17.1 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$11.1 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.51 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $379B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...